All the prostate cancer cell lines studied so far that exhibited hypoglycosylated α-DG in terms of matriglycan levels (Table 2) had concomitantly lost their ability to bind laminin, and the same has been evidenced for cervical cancer, glioblastoma, lung cancer and in the vast majority of breast cancer lines. Here, LAMB2 is linked to prostate cancer.